Arrowhead Pharmaceuticals, Inc. ( ARWR ) Q2 2026 Earnings Call May 7, 2026 4:30 PM EDT Company Participants Vincent Anzalone - Head of Investor Relations & VP Dr. Christopher Anzalone - Chairman, CEO & President Andy Davis - SVP of Cardiovascular & Head of Metabolic Franchise James Hamilton - Chief Medical Officer and Head of R&D Daniel Apel - Chief Financial Officer Conference Call Participants Edward Tenthoff - Piper Sandler & Co., Research Division Jason Gerberry - BofA Securities, Research Division Ron Feiner - JPMorgan Chase & Co, Research Division Avraham Novick - Morgan Stanley, Research Division Maurice Raycroft - Jefferies LLC, Research Division Joseph Thome - TD Cowen, Research Division Patrick Trucchio - H.C.…